Abraham Ceesay sold $374K of Rapport Therapeutics, Inc. (RAPP) stock

Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics, Inc. (RAPP), sold 8,210 shares of RAPP stock worth $374K, per an SEC Form 4 filed Sep 9, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 8, 2026, 1 day before it was made public.

RAPP has moved -14.0% since the trade date, from $46.09 to $39.66 (Sep 21, 2026 close).